Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Authors
Keywords
-
Journal
Journal of Obesity & Metabolic Syndrome
Volume 32, Issue 3, Pages 197-213
Publisher
Korean Society for the Study of Obesity
Online
2023-09-13
DOI
10.7570/jomes23052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- (2023) Mary E. Rinella et al. HEPATOLOGY
- Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
- (2023) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis
- (2023) Michael Harring et al. Clinical Gastroenterology and Hepatology
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- (2023) Mary E. Rinella et al. HEPATOLOGY
- An international multidisciplinary consensus statement on MAFLD and the risk of CVD
- (2023) Xiao-Dong Zhou et al. Hepatology International
- Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy
- (2023) Wah-Loong Chan et al. Hepatology International
- Association between handgrip strength, nonalcoholic fatty liver disease, advanced hepatic fibrosis and its modifiers: evidence from the NHANES database of the US
- (2023) Xiaohong Zhao et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease
- (2023) Michihiro Iwaki et al. Nutrients
- Mediterranean Diet and Sarcopenia Features in Apparently Healthy Adults over 65 Years: A Systematic Review
- (2023) Sousana K. Papadopoulou et al. Nutrients
- Whey Protein Supplementation with or without Vitamin D on Sarcopenia-Related Measures: A Systematic Review and Meta-Analysis
- (2023) Nasrin Nasimi et al. Advances in Nutrition
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
- (2023) Ferenc E Mózes et al. Lancet Gastroenterology & Hepatology
- Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
- (2023) Margaret LP Teng et al. Clinical and Molecular Hepatology
- Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
- (2023) Rachel Sinha et al. Journal of Obesity & Metabolic Syndrome
- Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease
- (2023) Shahreedhan Shahrani et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
- (2023) Hong-Kyu Kim et al. Clinical and Molecular Hepatology
- Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity
- (2023) Ji-Hee Haam et al. Journal of Obesity & Metabolic Syndrome
- The metabolic triad of non‐alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment
- (2022) Bertrand Cariou DIABETES OBESITY & METABOLISM
- Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease
- (2022) Wah‐Kheong Chan et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
- (2022) Yongin Cho et al. BMC Medicine
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Nonalcoholic Fatty Liver Disease and Accelerated Loss of Skeletal Muscle Mass: A Longitudinal Cohort Study
- (2022) Dong Hyun Sinn et al. HEPATOLOGY
- Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
- (2022) Darren Jun Hao Tan et al. LANCET ONCOLOGY
- Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis
- (2022) Dwijo Anargha Sindhughosa et al. Scientific Reports
- Global multi-stakeholder endorsement of the MAFLD definition
- (2022) Nahum Méndez-Sánchez et al. Lancet Gastroenterology & Hepatology
- Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
- (2022) Youn Huh et al. Journal of Obesity & Metabolic Syndrome
- Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals
- (2022) Cheng Han Ng et al. Expert Review of Gastroenterology & Hepatology
- 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
- (2022) Nuha A. ElSayed et al. DIABETES CARE
- 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
- (2022) Nuha A. ElSayed et al. DIABETES CARE
- Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
- (2022) Lee-Ling Lim et al. Nature Reviews Endocrinology
- Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database
- (2021) Christiane Lundegaard Haase et al. INTERNATIONAL JOURNAL OF OBESITY
- Sarcopenia in nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality in the United States
- (2021) Donghee Kim et al. LIVER INTERNATIONAL
- The effect of vitamin D plus protein supplementation on sarcopenia: A systematic review and meta-analysis of randomized controlled trials
- (2021) Nifon K. Gkekas et al. MATURITAS
- Endorsing the redefinition of fatty liver disease
- (2021) Soek Siam Tan et al. Lancet Gastroenterology & Hepatology
- Diagnosis, evaluation, and management of ascites and hepatorenal syndrome
- (2021) Scott W. Biggins et al. HEPATOLOGY
- Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
- (2021) Fu-Shun Yen et al. BMC GASTROENTEROLOGY
- Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
- (2021) Jerome Boursier et al. DIABETES & METABOLISM
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
- (2021) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- Sarcopenia and frailty in decompensated cirrhosis
- (2021) Puneeta Tandon et al. JOURNAL OF HEPATOLOGY
- 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
- (2021) Kyu Yeon Hur et al. Diabetes & Metabolism Journal
- 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
- (2021) Michael H. Le et al. Clinical Gastroenterology and Hepatology
- Baveno VII – Renewing consensus in portal hypertension
- (2021) Roberto de Franchis et al. JOURNAL OF HEPATOLOGY
- Modelling NAFLD disease burden in four Asian regions-2019-2030
- (2020) Chris Estes et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Rohit Loomba et al. GASTROENTEROLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
- (2020) Yasaman Vali et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Clinical Performance of Flash Glucose Monitoring System in Patients with Liver Cirrhosis and Diabetes Mellitus
- (2020) Dalila Costa et al. Scientific Reports
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- ESPEN practical guideline: Clinical nutrition in liver disease
- (2020) Stephan C. Bischoff et al. CLINICAL NUTRITION
- NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
- (2020) Giovanni Targher et al. DIABETES & METABOLISM
- The effect of daily protein supplementation, with or without resistance training for 1 year, on muscle size, strength, and function in healthy older adults: A randomized controlled trial
- (2020) Kenneth H Mertz et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
- (2019) Càndid Villanueva et al. LANCET
- The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
- (2019) Aino Latva-Rasku et al. DIABETES CARE
- Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis
- (2019) Wah-Kheong Chan et al. Clinical Gastroenterology and Hepatology
- Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
- (2019) Fabio Nascimbeni et al. ATHEROSCLEROSIS
- Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis
- (2019) L. Turco et al. Clinical Gastroenterology and Hepatology
- Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
- (2019) Stanley Khoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
- (2019) Sabine Kahl et al. DIABETES CARE
- Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
- (2018) W.-K. Chan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Treatment of Dyslipidemia in Common Liver Diseases
- (2018) Elizabeth K. Speliotes et al. Clinical Gastroenterology and Hepatology
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring
- (2018) Fumi Honda et al. PLoS One
- OUP accepted manuscript
- (2018) AGE AND AGEING
- Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis
- (2018) Naga S. Addepally et al. DIGESTIVE DISEASES AND SCIENCES
- Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites
- (2018) Tammo L. Tergast et al. Clinical and Translational Gastroenterology
- Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
- (2018) Kenneth Cusi et al. DIABETES OBESITY & METABOLISM
- Screening for non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography
- (2018) Lee‐Lee Lai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management
- (2018) Elsa Dent et al. Journal of Nutrition Health & Aging
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- (2017) Paul K. Whelton et al. HYPERTENSION
- Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment
- (2017) Vincent Wai-Sun Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
- (2017) Bo Kyung Koo et al. JOURNAL OF HEPATOLOGY
- Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
- (2017) Erin A. Bohula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- (2016) Stuart McPherson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus
- (2016) S. Gentile et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study
- (2016) Juan G. Abraldes et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study
- (2016) George Boon-Bee Goh et al. LIVER INTERNATIONAL
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Clinical outcomes of cryptogenic compared with non-cryptogenic cirrhosis: A retrospective cohort study
- (2015) Omar Kadhim Mohammed et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Lifestyle Weight-Loss Intervention Outcomes in Overweight and Obese Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2015) Marion J. Franz et al. Journal of the Academy of Nutrition and Dietetics
- SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes
- (2015) Theodore K. Malmstrom et al. Journal of Cachexia Sarcopenia and Muscle
- Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus
- (2014) André J. Scheen CLINICAL PHARMACOKINETICS
- Review article: prescribing medications in patients with cirrhosis - a practical guide
- (2013) J. H. Lewis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment
- (2013) S. Macha et al. DIABETES OBESITY & METABOLISM
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
- (2013) Robert J. Wong et al. HEPATOLOGY
- Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
- (2013) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
- (2011) E. Boettcher et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis
- (2011) Carmen C. Franz et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
- (2011) Vincent Wai-Sun Wong et al. GUT
- Role of Continuous Subcutaneous Insulin Infusion (Insulin Pump) in Reducing Blood Glucose in Four Patients with Type 2 Diabetes and Cirrhosis: A Case Series
- (2010) Johny J. Kannampilly Diabetes Technology & Therapeutics
- High prevalence of diabetes mellitus in patients with liver cirrhosis
- (2010) N. Wlazlo et al. DIABETIC MEDICINE
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started